Hematology drug shortages
13 drugs in this therapeutic category currently listed in the FDA Drug Shortage Database.
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 04/07/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 04/07/2026
Desmopressin Acetate Spray
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/02/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/01/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Shortage of an inactive ingredient component
- Updated
- 04/01/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 04/01/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 03/27/2026
Heparin Sodium Injection
- Category
- Hematology
- Reason
- Not specified
- Updated
- 03/27/2026
Desmopressin Acetate Spray
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 09/17/2025
Desmopressin Acetate Spray
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 09/17/2025
Desmopressin Acetate Spray
- Category
- Hematology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 09/17/2025
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.